{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:44:30Z","timestamp":1787161470296,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ijantimicag.2014.08.008","type":"journal-article","created":{"date-parts":[[2014,9,27]],"date-time":"2014-09-27T16:12:17Z","timestamp":1411834337000},"page":"493-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Unacylated tridecaptin A1 acts as an effective sensitiser of Gram-negative bacteria to other antibiotics"],"prefix":"10.1016","volume":"44","author":[{"given":"Stephen A.","family":"Cochrane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Vederas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0005","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.ijantimicag.2013.04.007","article-title":"Antimicrobial resistance: action to combat the rising microbial challenges","volume":"42","author":"Paphitou","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0010","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/ja.2013.86","article-title":"Antibiotics in the clinical pipeline in 2013","volume":"66","author":"Butler","year":"2013","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nchembio.1205","article-title":"Systems-level antimicrobial drug and drug synergy discovery","volume":"9","author":"Roemer","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1476-0711-11-32","article-title":"Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports","volume":"11","author":"Lee","year":"2012","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0030","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/648451","article-title":"Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"30","author":"Gasink","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.drup.2012.06.001","article-title":"Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii","volume":"15","author":"Karah","year":"2012","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0040","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"European Network on Carbapenemases. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe","volume":"18","author":"Cant\u00f3n","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0045","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1128\/AAC.00405-08","article-title":"Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents","volume":"52","author":"Vaara","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0050","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/jac\/dkq072","article-title":"Novel polymyxin derivatives are effective in treating experimental Escherichia coli peritoneal infection in mice","volume":"65","author":"Vingsbo Lundberg","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.peptides.2012.03.033","article-title":"Novel polymyxin derivatives are less cytotoxic than polymyxin B to renal proximal tubular cells","volume":"35","author":"Mingeot-Leclercq","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0060","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jac\/dks438","article-title":"Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens","volume":"68","author":"Vaara","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0065","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijantimicag.2012.10.005","article-title":"The novel polymyxin derivative NAB739 is remarkably less cytotoxic than polymyxin B and colistin to human kidney proximal tubular cells","volume":"41","author":"Vaara","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2478\/s11535-009-0031-3","article-title":"Lipopeptides as anti-infectives: a practical perspective","volume":"4","author":"Pirri","year":"2009","journal-title":"Cent Eur J Biol"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0075","doi-asserted-by":"crossref","DOI":"10.1002\/med.21321","article-title":"Lipopeptides from Bacillus and Paenibacillus spp.: a gold mine of antibiotic candidates","author":"Cochrane","year":"2014","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0080","doi-asserted-by":"crossref","first-page":"652","DOI":"10.7164\/antibiotics.31.652","article-title":"The structure of tridecaptin A (studies on antibiotics from the genus Bacillus. XXIV)","volume":"31","author":"Kato","year":"1978","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cbic.201300595","article-title":"Biochemical, structural, and genetic characterization of tridecaptin A1, an antagonist of Campylobacter jejuni","volume":"15","author":"Lohans","year":"2014","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0090","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1021\/jm401779d","article-title":"Synthesis and structure\u2013activity relationship studies of N-terminal analogues of the antimicrobial peptide tridecaptin A1","volume":"57","author":"Cochrane","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0095","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/303526a0","article-title":"Sensitization of Gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide","volume":"303","author":"Vaara","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1128\/AAC.25.6.701","article-title":"Susceptibility of Gram-negative bacteria to polymyxin B nonapeptide","volume":"25","author":"Viljanen","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0105","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/AAC.01439-09","article-title":"A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane","volume":"54","author":"Vaara","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbamem.2005.02.010","article-title":"Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843","volume":"1711","author":"Thennarasu","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-59745-246-5_13","article-title":"Methods for assessing the structure and function of cationic antimicrobial peptides","volume":"142","author":"Pate","year":"2008","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0003-2697(80)90269-9","article-title":"Colorimetric determination of phospholipids with ammonium ferrothiocyanate","volume":"104","author":"Stewart","year":"1980","journal-title":"Anal Biochem"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0130","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1128\/AAC.50.4.1449-1457.2006","article-title":"Insights into in vitro activities of lantibiotics from gallidermin and epidermin mode-of-action studies","volume":"50","author":"Bonelli","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/14.suppl_D.7","article-title":"Mode of action and in-vitro activity of vancomycin","volume":"14","author":"Watanakkunakorn","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0140","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1128\/AAC.34.6.1220","article-title":"Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032)","volume":"34","author":"Capepari","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/10408399409527650","article-title":"Nisin as a model food preservative","volume":"34","author":"Hansen","year":"1994","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.ijantimicag.2014.08.008_bib0150","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/cbic.201402024","article-title":"Key residues in octyl-tridecaptin A1 analogues linked to stable secondary structure in the membrane","volume":"15","author":"Cochrane","year":"2014","journal-title":"ChemBioChem"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914002830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857914002830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T23:32:35Z","timestamp":1538177555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857914002830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0924857914002830"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.08.008","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unacylated tridecaptin A1 acts as an effective sensitiser of Gram-negative bacteria to other antibiotics","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}